BRL-301 Clinical Trials

1 actively recruiting trial

Also known as: Allogeneic Anti-CD19 CAR T cells

Filter by location:

Other1 trial

Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.